Trials / Completed
CompletedNCT01914003
Congenital Sucrase-Isomaltase Deficiency (CSID) Genetic Prevalence Study (GPS)
A Multi-Center Study of the Prevalence of Known Congenital Sucrase-Isomaltase Deficiency (CSID) Genetic Variants and Functional Sucrase Activity by 13C-Sucrose Breath Test in Children With Chronic Diarrhea or Chronic Abdominal Pain
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 53 (actual)
- Sponsor
- QOL Medical, LLC · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Congenital sucrose-isomaltase deficiency (CSID) is a rare, genetic disease in which mutations in the sucrose-isomaltase (SI) gene cause digestion problems of sucrose resulting in diarrhea and abdominal pain. Children with chronic, idiopathic diarrhea or abdominal pain will have their sucrose-isomaltase gene assessed for a panel of known CSID mutations to determine the prevalence of these mutations in an enriched population and also determine functional deficiency using a breath test.
Conditions
Timeline
- Start date
- 2013-05-01
- Primary completion
- 2015-05-01
- Completion
- 2015-07-01
- First posted
- 2013-08-01
- Last updated
- 2017-11-06
- Results posted
- 2016-10-10
Locations
19 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01914003. Inclusion in this directory is not an endorsement.